Pharvaris NV
NASDAQ:PHVS
Pharvaris NV
NASDAQ:PHVS
Price:
28.56
USD
-3.02%
Market Closed
Market Cap:
$1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pharvaris NV
NASDAQ:PHVS
|
NL |
|
M
|
Mega Corp Ltd
BSE:531417
|
IN |
|
Venky's (India) Ltd
NSE:VENKEYS
|
IN |
|
Daiseki Eco Solution Co Ltd
TSE:1712
|
JP |
|
S
|
Sona Nanotech Inc
CNSX:SONA
|
CA |
|
Isiklar Enerji ve Yapi Holding AS
IST:IEYHO.E
|
TR |
|
Everbright Grand China Assets Ltd
HKEX:3699
|
HK |
|
Osaka Titanium Technologies Co Ltd
TSE:5726
|
JP |
|
Huber+Suhner AG
LSE:0QNH
|
CH |
|
H
|
Hap Seng Plantations Holdings Bhd
KLSE:HSPLANT
|
MY |
|
B
|
Bellavista Resources Ltd
ASX:BVR
|
AU |
|
Watkin Jones PLC
LSE:WJG
|
UK |
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
CN |
|
E
|
Energa SA
WSE:ENG
|
PL |
|
Renishaw PLC
LSE:RSW
|
UK |
|
JTEKT India Ltd
NSE:JTEKTINDIA
|
IN |
|
Harbin Pharmaceutical Group Co Ltd
SSE:600664
|
CN |
Balance Sheet
Balance Sheet Decomposition
Pharvaris NV
Pharvaris NV
Balance Sheet Decomposition is not available for
Pharvaris NV
Pharvaris NV
Balance Sheet
Pharvaris NV
Pharvaris NV
Currency: EUR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
5
|
20
|
99
|
209
|
162
|
391
|
281
|
|
| Cash Equivalents |
5
|
20
|
99
|
209
|
162
|
391
|
281
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
0
|
1
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
5
|
6
|
6
|
|
| Total Current Assets |
5
|
21
|
101
|
212
|
167
|
398
|
289
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
21
+281%
|
101
+391%
|
212
+110%
|
168
-21%
|
399
+138%
|
291
-27%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
6
|
3
|
5
|
|
| Accrued Liabilities |
0
|
1
|
5
|
4
|
11
|
11
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
0
|
1
|
|
| Total Current Liabilities |
1
|
2
|
5
|
7
|
18
|
15
|
23
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
1
N/A
|
2
+280%
|
5
+179%
|
7
+34%
|
19
+161%
|
15
-21%
|
24
+61%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
4
|
4
|
6
|
7
|
|
| Retained Earnings |
10
|
18
|
43
|
78
|
144
|
238
|
363
|
|
| Additional Paid In Capital |
15
|
37
|
138
|
279
|
289
|
616
|
624
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
19
+274%
|
96
+412%
|
205
+114%
|
149
-27%
|
384
+157%
|
268
-30%
|
|
| Total Liabilities & Equity |
5
N/A
|
21
+281%
|
101
+391%
|
212
+110%
|
168
-21%
|
399
+138%
|
291
-27%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
32
|
32
|
32
|
33
|
34
|
52
|
54
|
|
Switch to:
Switch to:
See Also
Discover More
